The Trump administration is making it easier for individuals to opt out of ObamaCare’s individual mandate.

In a rare moment of bipartisanship, the Senate overwhelmingly passed on Monday evening a sweeping package of bills aimed at addressing the nation’s deadly opioid epidemic.

Federal officials on Monday gave the go-ahead to the proposed merger between Cigna, one of the nation’s largest health insurers, and Express Scripts, a major pharmacy benefit manager.

House Republicans on Thursday blocked a drug pricing amendment supported by President Trump from inclusion in a health-care spending bill.

In the shadow of Silicon Valley, the hub of the world’s digital revolution, California officials still submit their records to the feds justifying billions in Medicaid spending the old-fashioned way: on paper.

Starting next year, Medicare Advantage plans will be able to add restrictions on expensive, injectable drugs administered by doctors to treat cancer, rheumatoid arthritis, macular degeneration and other serious diseases.